Table 1 Comparison of general clinical data
From: Comparison of transvaginal mesh surgery and robot-assisted sacrocolpopexy for pelvic organ prolapse
TVM group (n = 39) | RSC group (n = 37) | p-value | |
|---|---|---|---|
Age (years) | 72.0 (47–87) | 73.0 (56–86) | 0.963 |
BMI (kg/m2) | 24.7 (18.5–32.7) | 24.5 (17.9–32.0) | 0.868 |
POP-Q stage | < 0.005 | ||
Stage I | 0 (0%) | 0 (0%) | |
Stage II | 9 (23.1%) | 21 (56.7%) | |
Stage III | 24 (61.5%) | 11 (29.7%) | |
Stage IV | 6 (15.4%) | 5 (13.5%) | |
Type of POP | < 0.05 | ||
Cystocele | 18 (46.2%) | 2 (5.4%) | |
Uterine prolapse | 0 (0%) | 21 (56.8%) | |
Cystocele + uterine prolapse | 19 (48.7%) | 13 (35.1%) | |
Cystocele + rectocele | 1 (2.6%) | 1 (2.7%) | |
Cystocele + uterine prolapse + rectocele | 1 (2.6%) | 0 (0%) | |